Hanxiao Chen

643 total citations
34 papers, 388 citations indexed

About

Hanxiao Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Hanxiao Chen has authored 34 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Hanxiao Chen's work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (16 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Hanxiao Chen is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (16 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Hanxiao Chen collaborates with scholars based in China, Ethiopia and United States. Hanxiao Chen's co-authors include Jun Zhao, Tongtong An, Minglei Zhuo, Meina Wu, Xue Yang, Jia Zhong, Ziping Wang, Jianjie Li, Yuyan Wang and Yujia Chi and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hanxiao Chen

33 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanxiao Chen China 14 199 192 111 64 54 34 388
M Paesmans Belgium 5 225 1.1× 196 1.0× 159 1.4× 75 1.2× 52 1.0× 6 455
Jan Nyrop Jakobsen Denmark 10 195 1.0× 284 1.5× 153 1.4× 111 1.7× 24 0.4× 18 474
Ryo Ko Japan 12 299 1.5× 392 2.0× 122 1.1× 87 1.4× 31 0.6× 60 547
Ettie Piura Israel 9 181 0.9× 98 0.5× 202 1.8× 61 1.0× 51 0.9× 13 383
Carminia M. Della Corte Italy 7 139 0.7× 103 0.5× 129 1.2× 71 1.1× 19 0.4× 14 323
L. Paz-Ares Spain 9 291 1.5× 215 1.1× 97 0.9× 40 0.6× 15 0.3× 51 374
Sushma Jonna United States 8 208 1.0× 203 1.1× 202 1.8× 180 2.8× 23 0.4× 14 452
Sakiko Otani Japan 13 465 2.3× 404 2.1× 142 1.3× 92 1.4× 84 1.6× 45 613
Seiji Kosaihira Japan 9 174 0.9× 227 1.2× 153 1.4× 53 0.8× 32 0.6× 14 361

Countries citing papers authored by Hanxiao Chen

Since Specialization
Citations

This map shows the geographic impact of Hanxiao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanxiao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanxiao Chen more than expected).

Fields of papers citing papers by Hanxiao Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanxiao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanxiao Chen. The network helps show where Hanxiao Chen may publish in the future.

Co-authorship network of co-authors of Hanxiao Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Hanxiao Chen. A scholar is included among the top collaborators of Hanxiao Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanxiao Chen. Hanxiao Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Jing, Hanxiao Chen, Zhenlong Wang, & Xue Li. (2025). Multi-recognition sites and integrated self-powered chip: Trifurcated DNA hairpin circular walker in cancer biomarker detection. International Journal of Biological Macromolecules. 320(Pt 3). 146063–146063.
2.
Chen, Hanxiao, Xiangjuan Ma, Jie Liu, et al.. (2024). Real-world evaluation of first-line treatment of extensive-stage small-cell lung cancer with atezolizumab plus platinum/etoposide: a focus on patients with brain metastasis. Clinical & Translational Oncology. 26(7). 1664–1673. 2 indexed citations
3.
Kong, Ling‐Dong, Minglei Zhuo, Tongtong An, et al.. (2024). Women patients with small‐cell lung cancer using immunotherapy in a real‐world cohort achieved long‐term survival. Thoracic Cancer. 15(23). 1727–1738. 1 indexed citations
4.
Zhu, Lihang, Jonathan Nimal Selvaraj, Lincai Ye, et al.. (2024). Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventions. Nature Communications. 15(1). 7996–7996. 8 indexed citations
6.
7.
8.
Zhu, Sha, Hui Xu, Wenting Xu, et al.. (2021). Differential diagnostic ability of 18F-FDG PET/CT radiomics features between renal cell carcinoma and renal lymphoma. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 65(1). 72–78. 16 indexed citations
9.
Li, Jianjie, Yujia Chi, Guang Cao, et al.. (2021). Efficacy and safety of pemetrexed maintenance chemotherapy for advanced non-small cell lung cancer in a real-world setting. Journal of Thoracic Disease. 13(3). 1813–1821. 6 indexed citations
10.
Jia, Bo, Qiwen Zheng, Jianjie Li, et al.. (2021). Evaluation of different treatment strategies between right-sided and left-sided pneumonectomy for stage I–IIIA non-small cell lung cancer patients. Journal of Thoracic Disease. 13(3). 1799–1812. 4 indexed citations
12.
Chen, Hanxiao & Jun Zhao. (2020). KRAS oncogene may be another target conquered in non‐small cell lung cancer (NSCLC). Thoracic Cancer. 11(12). 3425–3435. 10 indexed citations
13.
Chen, Hanxiao, et al.. (2020). NFIB functions as an oncogene in estrogen receptor-positive breast cancer and is regulated by miR-205-5p. Pathology - Research and Practice. 216(12). 153236–153236. 4 indexed citations
14.
Wang, Yuyan, Qiwen Zheng, Bo Jia, et al.. (2020). Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database. Frontiers in Oncology. 10. 626–626. 19 indexed citations
15.
16.
Wang, Shuhang, Hanxiao Chen, Jia Zhong, et al.. (2019). Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung. Lung Cancer. 135. 116–122. 10 indexed citations
17.
Yu, Jiangyong, Shuhang Wang, Wei Zhao, et al.. (2018). Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer. Clinical Cancer Research. 24(9). 2148–2158. 47 indexed citations
18.
Zhuo, Minglei, Hanxiao Chen, Tianzhuo Zhang, et al.. (2018). The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients. Cancer Biomarkers. 22(3). 467–476. 31 indexed citations
19.
20.
Liu, Xiuju, Qiwen Zheng, Hanxiao Chen, et al.. (2018). Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer. Thoracic Cancer. 9(9). 1166–1173. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026